Equities
  • Price (EUR)5.57
  • Today's Change-0.036 / -0.64%
  • Shares traded10.00
  • 1 Year change-18.22%
  • Beta0.4233
Data delayed at least 15 minutes, as of Jul 11 2025 07:04 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Bausch Health Companies Inc grew revenues 9.91% from 8.76bn to 9.63bn while net income improved from a loss of 592.00m to a smaller loss of 46.00m.
Gross margin70.78%
Net profit margin-0.83%
Operating margin15.96%
Return on assets-0.30%
Return on equity--
Return on investment-0.38%
More ▼

Cash flow in USDView more

In 2024, Bausch Health Companies Inc increased its cash reserves by 24.84%, or 239.00m. The company earned 1.60bn from its operations for a Cash Flow Margin of 16.59%. In addition the company used 454.00m on investing activities and also paid 868.00m in financing cash flows.
Cash flow per share4.34
Price/Cash flow per share2.02
Book value per share-4.38
Tangible book value per share-65.31
More ▼

Balance sheet in USDView more

Bausch Health Companies Inc has a Debt to Total Capital ratio of 101.13%.
Current ratio1.35
Quick ratio0.9678
Total debt/total equity--
Total debt/total capital1.01
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.